Radiolabeling of liposomes for scintigraphic imaging

Methods in Enzymology

Volumn 373, Issue , 2003, Pages 234-248

  Laverman, Peter ^a   Boerman, Otto C ^a   Storm, Gert ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL INDIUM IN 111; ACETIC ACID DERIVATIVE; CALCIMYCIN; CHELATING AGENT; CHOLESTEROL; DAUNORUBICIN; DEFEROXAMINE; DIETHYLENETRIAMINETETRAACETIC ACID; DIPALMITOYLPHOSPHATIDYLCHOLINE; DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; DISTEAROYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLETHANOLAMINE; DOXORUBICIN; ETHANOLAMINE DERIVATIVE; GALIUM 67; GLUTATHIONE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; HYDRAZINE DERIVATIVE; INDIUM 111; IODINE 123; IODINE 125; LIPOSOME; MACROGOL; NICOTINAMIDE; NITRILOTRIACETIC ACID; PENTETIC ACID; RADIOISOTOPE; SPHINGOMYELIN; TECHNETIUM 99M; UNCLASSIFIED DRUG; UNINDEXED DRUG; DIAGNOSTIC AGENT; TECHNETIUM; TIN;

ARTICLE; CHELATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DRUG FORMULATION; DRUG MANUFACTURE; DRUG STABILITY; ENCAPSULATION; GAMMA RADIATION; HALF LIFE TIME; HUMAN; IMAGING; ISOTOPE LABELING; METHODOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MEDICINE; PRIORITY JOURNAL; RADIOACTIVITY; SCINTIGRAPHY; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; OXIDATION REDUCTION REACTION; RAT; SCINTISCANNING; STAINING; SYNTHESIS;

GALIUM;

ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; OXIDATION-REDUCTION; RADIONUCLIDE IMAGING; RATS; STAINING AND LABELING; TECHNETIUM; TIN;

EID: 1342333002     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(03)73015-8     Document Type: Article

References (35)

1. P. Laverman, O. C. Boerman, W. J. Oyen, E. T. Dams, G. Storm, and F. H. Corstens, Adv. Drug Deliv. Rev. 37, 225 (1999).
2. O. C. Boerman, P. Laverman, W. J. Oyen, F. H. Corstens, and G. Storm, Prog. Lipid Res. 39, 461 (2000).
3. W. T. Phillips, Adv. Drug Deliv. Rev. 37, 13 (1999).
4. W. T. Phillips and B. Goins, in "Handbook of Targeted Delivery of Imaging Agents" (V. P. Torchilin, Ed.), CRC Press, Boca Raton, FL, 1995.
5. G. L. Pool, M. E. French, R. A. Edwards, L. Huang, and R. H. Lumb, Lipids 17, 448 (1982).
6. F. A. Mettler and M. J. Guiberteau, "Essentials of Nuclear Medicine," 4th ed., W. B. Saunders, Philadelphia, 1998.
7. V. J. Caride, W. Taylor, J. A. Cramer, and A. Gottschalk, J. Nucl. Med 17, 1067 (1976).
8. I. R. McDougall, J. K. Dunnick, M. L. Goris, and J. P. Kriss, J. Nucl. Med 16, 488 (1975).
9. V. J. Caride, Int. J. Rad. Appl. Instrum. B 17, 35 (1990).
10. G. M. Barrat, N. S. Tüzel, and B. E. Ryman, in "Liposome Technology" (G. Gregoriadis, Ed.), CRC Press, Boca Raton, FL, 1984.
11. V. J. Richardson, K. Jeyasingh, R. F. Jewkes, B. E. Ryman, and M. H. Tattersall, Biochem. Soc. Trans. 5, 290 (1977).
12. W. G. Love, N. Amos, B. D. Williams, and I. W. Kellaway, J. Microencapsul. 6, 105 (1989).
13. J. R. Morgan, K. E. Williams, R. L. Davies, K. Leach, M. Thomson, and L. A. Williams, J. Med. Microbiol. 14, 213 (1981).
14. M. Alafandy, G. Goffinet, V. Umbrain, J. D'Haese, F. Camu, and F. J. Legros, Nucl. Med. Biol. 23, 881 (1996).
15. M. R. Mauk and R. C. Gamble, Anal. Biochem. 94, 302 (1979).
16. K. J. Hwang, J. E. Merriam, P. L. Beaumier, and K. F. S. Luk, Biochim. Biophys. Acta 716, 101 (1982).
17. P. L. Beaumier and K. J. Hwang, J. Nucl. Med. 23, 810 (1982).
18. A. Gabizon, J. Huberty, R. M. Straubinger, D. C. Price, and D. Papahadjopoulos, J. Liposome Res. 1, 123 (1988).
19. I. Ogihara-Umeda and S. Kojima, J. Nucl. Med. 29, 516 (1988).
20. M. L. Corvo, O. C. Boerman, W. J. Oyen, L. Van Bloois, M. E. Cruz, D. J. Crommelin, and G. Storm, Biochim. Biophys. Acta 1419, 325 (1999).
21. P. Laverman, M. G. Carstens, O. C. Boerman, E. T. Dams, W. J. G. Oyen, N. van Rooijen, F. H. M. Corstens, and G. Storm, J. Pharmacol. Exp. Ther. 298, 607 (2001).
22. P. Laverman and M. G. Carstens, Unpublished results (2000).
23. W. T. Phillips, A. S. Rudolph, B. Goins, J. H. Timmons, R. Klipper, and R. Blumhardt, Nucl. Med. Biol. 19, 539 (1992).
24. A. M. Peters, H. J. Danpure, S. Osman, R. J. Hawker, B. L. Henderson, H. J. Hodgson, J. D. Kelly, R. D. Neirinckx, and J. P. Lavender, Lancet 2, 946 (1986).
25. B. Goins, R. Klipper, and W. T. Phillips, J. Nucl. Med. 38, 179P (1997).
26. E. T. Dams, W. J. Oyen, O. C. Boerman, G. Storm, P. Laverman, P. J. Kok, W. C. Buijs, H. Bakker, J. W. van der Meer, and F. H. Corstens, J. Nucl. Med. 41, 622 (2000).
27. D. J. Hnatowich, B. Friedman, B. Clancy, and M. Novak, J. Nucl. Med. 22, 810 (1981).
28. Q. F. Ahkong and C. Tilcock, Int. J. Rad. Appl. Instrum. B 19, 831 (1992).
29. P. Laverman, A. H. Brouwers, E. T. Dams, W. J. Oyen, G. Storm, N. van Rooijen, F. H. Corstens, and O. C. Boerman, J. Pharmacol. Exp. Ther. 293, 996 (2000).
30. M. J. Abrams, M. Juweid, C. I. tenKate, D. A. Schwartz, M. M. Hauser, F. E. Gaul, A. J. Fuccello, R. H. Rubin, H. W. Strauss, and A. J. Fischman, J. Nucl. Med. 31, 2022 (1990).
31. P. Laverman, L. Van Bloois, O. C. Boerman, W. J. Oyen, F. H. Corstens, and G. Storm, J. Liposome Res. 10, 117 (2000).
32. H. J. Rennen, O. C. Boerman, E. B. Koenders, W. J. Oyen, and F. H. Corstens, Nucl. Med. Biol. 27, 599 (2000).
33. P. Laverman, E. T. Dams, W. J. Oyen, G. Storm, E. B. Koenders, R. Prevost, J. W. van der Meer, F. H. Corstens, and O. C. Boerman, J. Nucl. Med. 40, 192 (1999).
34. A. H. Brouwers, D. J. de Jong, E. T. Dams, W. J. Oyen, O. C. Boerman, P. Laverman, T. H. J. Naber, G. Storm, and F. H. Corstens, J. Drug Target. 8, 225 (2000).
35. P. Laverman, M. G. Carstens, G. Storm, and S. M. Moghimi, Biochim. Biophys. Acta. 1526, 227 (2001).